Combining bioreductive drugs and radiation for the treatment of solid tumors

被引：22

作者：

Stratford, IJ ^{[1
]}

Williams, KJ ^{[1
]}

Cowen, RL ^{[1
]}

Jaffar, M ^{[1
]}

机构：

[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England

来源：

SEMINARS IN RADIATION ONCOLOGY | 2003年 / 13卷 / 01期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1053/srao.2003.50008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Methods now exist for the identification of human tumors that contain significant numbers of hypoxic cells and are thereby suitable for treatment with bioreductive drugs to eliminate this refractory cell population. However, to fully exploit the potential of bioreductive drugs, they will need to be used in combination with other modalities likely to target the proliferating aerobic cells in the tumor. Radiation is the treatment that is most effective in killing aerobic cells; therefore, the present report reviews the available preclinical data on combined radiation/bioreductive drug treatments. Copyright 2003, Elsevier Science (USA). All rights reserved.

引用

页码：42 / 52

页数：11

共 84 条

[81] Hypoxia as a target for combined modality treatments [J].

Wouters, BG ;

Weppler, SA ;

Koritzinsky, M ;

Landuyt, W ;

Nuyts, S ;

Theys, J ;

Chiu, RK ;

Lambin, P .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (02) :240-257

[82] ENHANCEMENT OF RADIATION-INDUCED TUMOR-CELL KILLING BY THE HYPOXIC CELL TOXIN SR-4233 [J].

ZEMAN, EM ;

HIRST, VK ;

LEMMON, MJ ;

BROWN, JM .

RADIOTHERAPY AND ONCOLOGY, 1988, 12 (03) :209-218

[83] PRE-IRRADIATION AND POST-IRRADIATION RADIOSENSITIZATION BY SR-4233 [J].

ZEMAN, EM ;

BROWN, JM .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (04) :967-971

[84]

ZEMAN EM, 1968, INT J RADIAT ONCOL, V12, P1239

← 1 2 3 4 5 6 7 8 9 →